Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid drug for inducing skipping of variant exon of CD44 gene and increasing expression of normal type CD44 mRNA

Nucleic acid drug for inducing skipping of variant exon of CD44 gene and increasing expression of normal type CD44 mRNA

US Patent 10174319 · Granted Jan 8, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibition of myostatin signal by myostatin splice variant-derived protein and u2025
Therapeutic agent for glycogen storage disease type IA2024
Load port with non-contact sensor2022
Load port having movable member that abuts a pin2021
Antisense oligonucleotide controlling expression amount of TDP-43 and use thereo2021
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursor2017
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursor2017
Variable compression ratio device for internal combustion engine2017
Piston2017
Readthrough inducing agent and drug for treating genetic disease caused by nonse2016
Prophylactic or ameliorating agent for genetic diseases2016
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursor2016